ReDirection Therapy for Reducing CSAM Risk
Trial Summary
What is the purpose of this trial?
The creation and distribution of child sexual abuse material (CSAM) is a large-scale global problem. CSAM is sometimes referred to as child pornography. It includes images, videos, live-streaming, and any other material that depicts sexual acts with a child or adolescent (i.e., a person under the age of 18). It also includes material that shows a child or adolescent in a sexually suggestive or explicit manner partially clothed, or nude, and can include material that does or does not illustrate sexual activity. CSAM use is a problem that continues to drastically increase in size despite the numerous political, police, and technological initiatives that have been put forth as solutions. Previous research also suggests that many active CSAM users desire help to stop their use, but have experienced difficulties finding support that is anonymous. Thus, there is a great need for anonymous intervention programs that assist active and at-risk CSAM users in developing skills to manage their thoughts, feelings, and behaviours related to CSAM. ReDirection is a free, anonymous, online, self-guided, cognitive behavioural therapy (CBT)-based program for individuals concerned about their use or risk to use CSAM. The treatment program is based on many years of clinical experience working with patients who have committed sexual offences, and the results of several previous research projects. This study will implement a scientifically rigorous design (a three-armed randomized waitlist-controlled trial) to evaluate two versions of this intervention (ReDirection 1.0 and ReDirection 2.0). The primary difference between the two versions of ReDirection is the length of the program and whether it includes the option for asynchronous messaging with a ReDirection specialist. The study design compares ReDirection 1.0 and ReDirection 2.0 with a waitlist control group. Participants in the waitlist control will wait six weeks before starting active treatment. While on the waitlist, participants will respond to questions about ongoing about sexual urges and behaviours. Participants will be recruited directly from the ReDirection website, where they will be directed to a secure platform designed specifically for clinical trials of internet-mediated CBT. This platform is called Iterapi. Potential participants learn about the ReDirection program through advertisements on both the "Clearnet" and "Darknet." All trial activities, including participant registration, random assignment, intervention, and evaluation will be conducted via Iterapi. Treatment includes five-to-six modules over five-to-six weeks and the content includes CBT-based psychoeducation and exercises that aim to help participants gain greater understanding of, and skills to manage risky sexual thoughts, feelings, and behaviours.
Do I need to stop taking my current medications to join the trial?
The trial information does not specify whether you need to stop taking your current medications. It is best to consult with the trial organizers or your healthcare provider for guidance.
How is the ReDirection treatment different from other treatments for reducing CSAM risk?
ReDirection Therapy is unique because it specifically targets individuals with a sexual interest in minors who voluntarily seek help, focusing on reducing the risk of engaging with Child Sexual Abuse Material (CSAM). This approach is novel as it provides a confidential treatment service for non-forensic individuals, which is not commonly available in standard treatments for this condition.12345
Research Team
Carissa Augustyn, PhD
Principal Investigator
The Royal Ottawa Mental Health Centre
Eligibility Criteria
This trial is for individuals concerned about their use or risk of using child sexual abuse material (CSAM). Participants must be seeking anonymous support and willing to engage in a self-guided online cognitive behavioural therapy program. Specific eligibility criteria are not provided, but it's implied that participants should have internet access and be comfortable with the digital format.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Waitlist Control
Participants in the waitlist control will wait six weeks before starting active treatment, responding to questions about ongoing sexual urges and behaviours
Treatment
Participants receive the ReDirection program, which includes five-to-six modules over five-to-six weeks, with CBT-based psychoeducation and exercises
Follow-up
Participants are monitored for changes in urges to use CSAM and proclivity to offend, using modified SSAS and study-specific measures
Treatment Details
Interventions
- ReDirection 1.0
- ReDirection 2.0
- Waitlist
Find a Clinic Near You
Who Is Running the Clinical Trial?
The Royal Ottawa Mental Health Centre
Lead Sponsor
Johns Hopkins Bloomberg School of Public Health
Collaborator
Protect Children Organisation, Finland
Collaborator